Last reviewed · How we verify

Bacterial contamination

Ahmad Mustafa Mohamed Metwalley · Phase 2 active Biologic

This drug targets bacterial contamination by inhibiting bacterial growth and replication.

This drug targets bacterial contamination by inhibiting bacterial growth and replication. Used for Treatment of bacterial infections.

At a glance

Generic nameBacterial contamination
Also known asBacterial contamination presence of post processinf samples
SponsorAhmad Mustafa Mohamed Metwalley
ModalityBiologic
Therapeutic areaInfectious Diseases
PhasePhase 2

Mechanism of action

The exact molecular target or receptor is unknown, but it is believed to work by disrupting the bacterial cell wall, ultimately leading to cell death.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: